• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对同时接种麻疹、腮腺炎和风疹联合疫苗以及白喉-破伤风和脊髓灰质炎疫苗加强剂量的免疫反应。

Immune response to simultaneous administration of a combined measles, mumps and rubella vaccine with booster doses of diphtheria-tetanus and poliovirus vaccine.

作者信息

Giammanco G, Li Volti S, Salemi I, Giammanco Bilancia G, Mauro L

机构信息

Institute of Hygiene and Preventive Medicine, University of Catania, Italy.

出版信息

Eur J Epidemiol. 1993 Mar;9(2):199-202. doi: 10.1007/BF00158792.

DOI:10.1007/BF00158792
PMID:8519358
Abstract

A combined vaccine against measles (Edmonston-Zagreb 19 strain), mumps (Rubini strain) and rubella (Wistar RA 27/3 strain) was administered to a group of 46 children aged 10-12 months simultaneously with booster doses of compulsory diphtheria-tetanus toxoid and oral poliovirus vaccine. A second group of 53 children aged 15-24 months who had received booster doses of the compulsory vaccines 5 to 12 months before was also vaccinated. The same seroconversion rates (100%) and similar antibody titers for rubella were observed in both groups. The same seroconversion rates for mumps (93%) and similar rates for measles (98 and 94%) were observed in the two groups. Significantly lower antibody titers for measles and mumps were found in the first group, but they were compensated by an earlier protection, a reduction of number of visits for immunization, costs for the community, and improvement in parental compliance. These results confirm that Edmonston-Zagreb 19 and Rubini strains are still immunogenic even when they are combined with Wistar RA 27/3 strain. Moreover, a long term follow-up in order to verify the persistence of protective antibody levels in both groups of children, could suggest that combined measles, mumps and rubella vaccine could be given earlier (at 10-12 months of age), simultaneously with booster doses of diphtheria and tetanus toxoid and of trivalent oral poliovirus vaccine.

摘要

一种针对麻疹(埃德蒙斯顿-萨格勒布19株)、腮腺炎(鲁比尼株)和风疹(Wistar RA 27/3株)的联合疫苗被接种给了一组46名10至12个月大的儿童,同时还接种了白喉-破伤风类毒素加强剂和口服脊髓灰质炎疫苗。另一组53名15至24个月大的儿童,他们在5至12个月前已接种了强制疫苗的加强剂,也接种了该联合疫苗。两组中观察到风疹的血清转化率相同(100%)且抗体滴度相似。两组中腮腺炎的血清转化率相同(93%),麻疹的血清转化率相似(98%和94%)。第一组中麻疹和腮腺炎的抗体滴度明显较低,但它们通过更早的保护、减少免疫接种就诊次数、社区成本以及提高家长依从性得到了弥补。这些结果证实,即使埃德蒙斯顿-萨格勒布19株和鲁比尼株与Wistar RA 27/3株联合使用,它们仍然具有免疫原性。此外,为了验证两组儿童中保护性抗体水平的持久性而进行的长期随访可能表明,麻疹、腮腺炎和风疹联合疫苗可以更早(在10至12个月大时)接种,同时接种白喉和破伤风类毒素加强剂以及三价口服脊髓灰质炎疫苗。

相似文献

1
Immune response to simultaneous administration of a combined measles, mumps and rubella vaccine with booster doses of diphtheria-tetanus and poliovirus vaccine.对同时接种麻疹、腮腺炎和风疹联合疫苗以及白喉-破伤风和脊髓灰质炎疫苗加强剂量的免疫反应。
Eur J Epidemiol. 1993 Mar;9(2):199-202. doi: 10.1007/BF00158792.
2
Duration of the immune response to MMR vaccine in children of two age-different groups.两个不同年龄组儿童对麻腮风疫苗免疫反应的持续时间。
Eur J Epidemiol. 1993 May;9(3):311-4. doi: 10.1007/BF00146269.
3
Simultaneous administration of measles-mumps-rubella vaccine with booster doses of diphtheria-tetanus-pertussis and poliovirus vaccines.麻疹-腮腺炎-风疹疫苗与白喉-破伤风-百日咳加强疫苗及脊髓灰质炎疫苗同时接种。
Pediatrics. 1988 Feb;81(2):237-46.
4
Antibody levels to diphtheria, tetanus, and rubella in infants vaccinated while on PD: a Study of the Pediatric Peritoneal Dialysis Study Consortium.接受持续性不卧床腹膜透析(PD)的婴儿接种白喉、破伤风和风疹疫苗后的抗体水平:儿科腹膜透析研究联盟的一项研究
Adv Perit Dial. 1997;13:297-9.
5
Simultaneous administration of a diphtheria and tetanus toxoids and acellular pertussis vaccine with measles-mumps-rubella and oral poliovirus vaccines.白喉破伤风类毒素和无细胞百日咳疫苗与麻疹-腮腺炎-风疹疫苗及口服脊髓灰质炎病毒疫苗同时接种。
Am J Dis Child. 1993 Aug;147(8):854-7. doi: 10.1001/archpedi.1993.02160320056019.
6
Comparative evaluation of two combined measles-mumps-rubella vaccines based on AIK and Edmonston- Zagreb strains of measles virus.基于麻疹病毒AIK株和埃德蒙斯顿- Zagreb株的两种麻疹-腮腺炎-风疹联合疫苗的比较评价。
Kitasato Arch Exp Med. 1991 Sep;64(2-3):141-7.
7
Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.14至23月龄婴儿同时接种b型流感嗜血杆菌结合疫苗(脑膜炎球菌蛋白结合疫苗)与麻疹-腮腺炎-风疹疫苗或白喉-破伤风-百日咳疫苗及口服脊髓灰质炎疫苗的安全性、耐受性和免疫原性。
Pediatrics. 1990 Apr;85(4 Pt 2):682-9.
8
Current immunization practices. 1. Polio, diphtheria, tetanus, pertussis, measles, mumps, rubella, and influenza.
Postgrad Med. 1989 Feb 1;85(2):183-6, 188-90, 195-8. doi: 10.1080/00325481.1989.11700581.
9
Response to measles revaccination among toddlers in Saudi Arabia by the use of two different trivalent measles-mumps-rubella vaccines.
Trans R Soc Trop Med Hyg. 1999 Mar-Apr;93(2):214-9. doi: 10.1016/s0035-9203(99)90310-3.
10
Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella.使用不同的麻疹、腮腺炎、风疹联合疫苗进行初次接种和再次接种后的免疫反应。
Vaccine. 2000 Jan 31;18(14):1382-92. doi: 10.1016/s0264-410x(99)00397-7.

引用本文的文献

1
Effect of age at vaccination on the measles vaccine effectiveness and immunogenicity: systematic review and meta-analysis.疫苗接种年龄对麻疹疫苗有效性和免疫原性的影响:系统评价和荟萃分析。
BMC Infect Dis. 2020 Mar 29;20(1):251. doi: 10.1186/s12879-020-4870-x.
2
Evaluation of potentially achievable vaccination coverage of the second dose of measles containing vaccine with simultaneous administration and risk factors for missed opportunities among children in Zhejiang province, east China.中国东部浙江省麻疹含麻疹成分疫苗第二剂次同时接种潜在可实现接种率评估及漏种原因分析
Hum Vaccin Immunother. 2018 Apr 3;14(4):875-880. doi: 10.1080/21645515.2017.1419111. Epub 2018 Jan 23.
3

本文引用的文献

1
Edmonston-Zagreb strain of measles vaccine: epidemiologic evaluation in Yugoslavia.
Rev Infect Dis. 1983 May-Jun;5(3):558-63.
2
Effect of timing of measles vaccination on compliance with immunizations during the second year of life.麻疹疫苗接种时间对生命第二年免疫接种依从性的影响。
J Pediatr. 1983 Feb;102(2):186-90. doi: 10.1016/s0022-3476(83)80516-2.
3
Methodologic issues in the evaluation of vaccine effectiveness: measles vaccine at 12 vs. 15 months.疫苗效果评估中的方法学问题:12月龄与15月龄时的麻疹疫苗
Use of a microquantity enzyme immunoassay in a large-scale study of measles, mumps and rubella immunity in Italy.
微量酶免疫测定法在意大利麻疹、腮腺炎和风疹免疫大规模研究中的应用。
Eur J Clin Microbiol Infect Dis. 1998 Jan;17(1):49-52. doi: 10.1007/BF01584365.
4
[Mumps vaccines: virological basis].[腮腺炎疫苗:病毒学基础]
Soz Praventivmed. 1995;40(2):102-9. doi: 10.1007/BF01360324.
Am J Epidemiol. 1982 Sep;116(3):510-23. doi: 10.1093/oxfordjournals.aje.a113435.
4
Successful immunization of infants with and without maternal antibody by aerosolized measles vaccine. II. Vaccine comparisons and evidence for multiple antibody response.通过雾化麻疹疫苗对有或无母体抗体的婴儿进行成功免疫。II. 疫苗比较及多种抗体反应的证据。
JAMA. 1984 May 11;251(18):2363-71.
5
Immunisation of 4-6 month old Gambian infants with Edmonston-Zagreb measles vaccine.用埃德蒙斯顿- Zagreb麻疹疫苗对4至6个月大的冈比亚婴儿进行免疫接种。
Lancet. 1984 Oct 13;2(8407):834-7. doi: 10.1016/s0140-6736(84)90873-0.
6
Simultaneous administration of smallpox, measles, yellow fever, and diphtheria-pertussis-tetanus antigens to Nigerian children.向尼日利亚儿童同时接种天花、麻疹、黄热病和白喉-百日咳-破伤风抗原。
Bull World Health Organ. 1973;48(2):175-81.
7
[Field trial with a new human diploid cell vaccine (HDCV) against measles, mumps and rubella].[新型人二倍体细胞麻疹、腮腺炎和风疹疫苗(HDCV)的现场试验]
Schweiz Med Wochenschr. 1985 Nov 30;115(48):1727-30.
8
Response to measles vaccine in Haitian infants 6 to 12 months old. Influence of maternal antibodies, malnutrition, and concurrent illnesses.海地6至12个月大婴儿对麻疹疫苗的反应。母体抗体、营养不良和并发疾病的影响。
N Engl J Med. 1985 Aug 29;313(9):544-9. doi: 10.1056/NEJM198508293130904.
9
Benefits, risks and costs of immunization for measles, mumps and rubella.麻疹、腮腺炎和风疹免疫接种的益处、风险及成本
Am J Public Health. 1985 Jul;75(7):739-44. doi: 10.2105/ajph.75.7.739.
10
Rubini, a new live attenuated mumps vaccine virus strain for human diploid cells.鲁比尼,一种用于人二倍体细胞的新型减毒活腮腺炎疫苗病毒株。
Dev Biol Stand. 1986;65:29-35.